Health policy makers, decision makers and researchers will learn from the analysis of data while the research community will benefit from advances in Q methodology.
This three-year UK-based research project is funded by the MRC Methodology Panel. We investigate societal perspectives regarding the relative value of medical technologies which extend the lives of terminally ill patients.
As health technologies become ever more advanced and expensive, difficult decisions need to be made about which should be provided and under what circumstances the cost of a treatment is too high in relation to the expected health benefits.
Technologies exist which can extend the life of people who have a terminal illness by a small amount, but sometimes at great cost. Should they be provided by the National Health Service? What do members of the public and people with expertise and experience think? What views exist?
The project is led by Professor Rachel Baker, Professor of Health Economics at the Yunus Centre for Social Business and Health, Glasgow Caledonian University. Email email@example.com or phone + 44 (0)141 331 8246.